Vision

We approach the development of pharmaceuticals to treat aging and age related disease from a different angle.

Using unique species and proprietary paradigms, we determine novel interventions that have the capability to increase lifespan and healthspan not just by a few percent, but by orders of magnitude.

FOUNDERS

Simon Melov

Founder and CEO

Gordon Lithgow

Founder

Mark Lucanic

Founder and CTO

    Dr Melov is a Professor at the Buck Institute for Research on Aging, and is an expert in interventions to slow aging.

    Simon has received numerous NIH awards and sponsored research programs from biotech and the pharmaceutical industry.

    Simon holds a B.Sc in Human Genetics from the University of N.S.W. Australia, and a PhD in genetics from Imperial College London, UK.

    He is one of the founding faculty of the Buck Institute, and is a co-Founder and CEO of Gerostate Alpha.

    Dr Lithgow is Chief Academic Officer at the Buck Institute for Research on Aging, and is an expert on small molecules which can extend lifespan of model systems such as C. Elegans.

    Gordon is internationally recognized for his work on aging with numerous awards and prizes.

    Gordon obtained his B.Sc and PhD at the University of Glasgow, before working in the pharmaceutical industry. He then rejoined academia, and collaborated with Simon Melov in his post-doctoral studies, and has continued to collaborate with Dr Melov for nearly 25 years.

    Gordon joined the Buck Institute for Research on Aging in 2000, and is a co-founder of Gerostate Alpha.

    Dr Lucanic is Chief Technical officer of Gerostate Alpha. He is an expert in small molecule and genetic screens and has significant experience with high throughput technologies.

    Mark holds a Bachelor’s degree in Molecular, Cell and Developmental Biology from the University of California, Santa Cruz where he graduated with highest honors. He earned his PhD studying developmental neuroscience at the University of California.

    Dr Lucanic has collaborated with Dr’s Melov and Lithgow for over a decade, and prior to co-founding Gerostate Alpha was on the research faculty at the Buck Institute.

CONTACT

Fill in the form and we'll be in touch

Submitting Form...

The server encountered an error.

Form received.

FOUNDERS
CONTACT

We approach the development of pharmaceuticals to treat aging and age related disease from a different angle.

Using unique species and proprietary paradigms, we determine novel interventions that have the capability to increase lifespan and healthspan not just by a few percent, but by orders of magnitude.

FOUNDERS

    Dr Melov is a Professor at the Buck Institute for Research on Aging, and is an expert in interventions to slow aging.

    Simon has received numerous NIH awards and sponsored research programs from biotech and the pharmaceutical industry.

    Simon holds a B.Sc in Human Genetics from the University of N.S.W. Australia, and a PhD in genetics from Imperial College London, UK.

    He is one of the founding faculty of the Buck Institute, and is a co-Founder and CEO of Gerostate Alpha.

    Dr Lithgow is Chief Academic Officer at the Buck Institute for Research on Aging, and is an expert on small molecules which can extend lifespan of model systems such as C. Elegans.

    Gordon is internationally recognized for his work on aging with numerous awards and prizes.

    Gordon obtained his B.Sc and PhD at the University of Glasgow, before working in the pharmaceutical industry. He then rejoined academia, and collaborated with Simon Melov in his post-doctoral studies, and has continued to collaborate with Dr Melov for nearly 25 years.

    Gordon joined the Buck Institute for Research on Aging in 2000, and is a co-founder of Gerostate Alpha.

    Dr Lucanic is Chief Technical officer of Gerostate Alpha. He is an expert in small molecule and genetic screens and has significant experience with high throughput technologies.

    Mark holds a Bachelor’s degree in Molecular, Cell and Developmental Biology from the University of California, Santa Cruz where he graduated with highest honors. He earned his PhD studying developmental neuroscience at the University of California.

    Dr Lucanic has collaborated with Dr’s Melov and Lithgow for over a decade, and prior to co-founding Gerostate Alpha was on the research faculty at the Buck Institute.

CONTACT